Archive - October 2018
FDA Advisory Committee Recommends Approval of Shire’s Prucalopride (SHP555) for Chronic Idiopathic Constipation
After mixed signals, will Eisai and Biogen press on with Alzheimer’s hopeful?
Health driving London’s digital lead in Europe
BMS CEO tackles investor ‘frustrations’ on immuno-oncology
Novartis gains label boost for Cosentyx
Celgene to launch five new products through to 2020
Roche’s new flu pill Xofluza approved in US
Stressed Out? Your Brain Could Be Shrinking As A Result